JP2012517239A5 - - Google Patents

Download PDF

Info

Publication number
JP2012517239A5
JP2012517239A5 JP2011550155A JP2011550155A JP2012517239A5 JP 2012517239 A5 JP2012517239 A5 JP 2012517239A5 JP 2011550155 A JP2011550155 A JP 2011550155A JP 2011550155 A JP2011550155 A JP 2011550155A JP 2012517239 A5 JP2012517239 A5 JP 2012517239A5
Authority
JP
Japan
Prior art keywords
influenza virus
virus
reassortant influenza
donor viruses
reassortant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011550155A
Other languages
English (en)
Japanese (ja)
Other versions
JP5818693B2 (ja
JP2012517239A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/022970 external-priority patent/WO2010093537A2/en
Publication of JP2012517239A publication Critical patent/JP2012517239A/ja
Publication of JP2012517239A5 publication Critical patent/JP2012517239A5/ja
Application granted granted Critical
Publication of JP5818693B2 publication Critical patent/JP5818693B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011550155A 2009-02-12 2010-02-03 インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体 Expired - Fee Related JP5818693B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15209409P 2009-02-12 2009-02-12
US61/152,094 2009-02-12
PCT/US2010/022970 WO2010093537A2 (en) 2009-02-12 2010-02-03 Influenza hemagglutinin and neuraminidase variants

Publications (3)

Publication Number Publication Date
JP2012517239A JP2012517239A (ja) 2012-08-02
JP2012517239A5 true JP2012517239A5 (https=) 2013-03-14
JP5818693B2 JP5818693B2 (ja) 2015-11-18

Family

ID=42562246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011550155A Expired - Fee Related JP5818693B2 (ja) 2009-02-12 2010-02-03 インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体

Country Status (11)

Country Link
US (2) US8613935B2 (https=)
EP (1) EP2396033B1 (https=)
JP (1) JP5818693B2 (https=)
CN (1) CN102361649A (https=)
AU (1) AU2010213966B2 (https=)
BR (1) BRPI1008549A2 (https=)
CA (1) CA2752205A1 (https=)
MX (2) MX2011008497A (https=)
RU (2) RU2535970C2 (https=)
SG (2) SG173642A1 (https=)
WO (1) WO2010093537A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0610525Y2 (ja) 1986-02-06 1994-03-16 三洋電機株式会社 キヤプスタンモ−タ制御回路
JP4980895B2 (ja) 2004-05-25 2012-07-18 メディミューン,エルエルシー インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
CN104140958A (zh) 2006-08-09 2014-11-12 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
SG173642A1 (en) 2009-02-12 2011-09-29 Medimmune Llc Influenza hemagglutinin and neuraminidase variants
JP2013541528A (ja) 2010-09-21 2013-11-14 マサチューセッツ インスティテュート オブ テクノロジー ヒト適応haポリペプチド、ワクチン、およびインフルエンザの処置
CN108103084B (zh) * 2017-11-21 2020-06-26 浙江迪福润丝生物科技有限公司 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992522A (en) 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
US4071618A (en) 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
JPS57136528A (en) 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4634666A (en) 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
US4752473A (en) * 1984-10-12 1988-06-21 The Regents Of The University Of California Expression of glycosylated human influenza hemagglutinin proteins
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5166057A (en) 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5840520A (en) 1989-08-28 1998-11-24 Aviron Recombinant negative strand RNA virus expression systems
US6001634A (en) 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
US5665362A (en) 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
EP1473361A3 (en) 1992-04-14 2004-11-17 The Mount Sinai School Of Medicine, Of The City University Of New York Genetically engineered attenuated viruses
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
ATE257175T1 (de) 1994-07-18 2004-01-15 Conzelmann Karl Klaus Prof Dr Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
US5789229A (en) 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
US5716821A (en) 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
US6146873A (en) 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5756341A (en) 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US7153510B1 (en) 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
ATE181112T1 (de) 1995-08-09 1999-06-15 Schweiz Serum & Impfinst Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
US6264957B1 (en) 1995-09-27 2001-07-24 The United States Of America As Represented By The Department Of Health And Human Services Product of infectious respiratory syncytial virus from cloned nucleotide sequences
DK0864645T3 (da) 1995-10-31 2005-10-24 Dnavec Research Inc Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
DK0863202T3 (da) 1995-11-01 2010-09-27 Dnavec Research Inc Rekombinant Sendai-virus
US6090391A (en) 1996-02-23 2000-07-18 Aviron Recombinant tryptophan mutants of influenza
WO1998002530A1 (en) 1996-07-15 1998-01-22 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
CA2265554A1 (en) 1996-09-27 1998-04-02 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
BR9809456B1 (pt) 1997-05-23 2011-06-28 molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, partìcula de piv infeciosa, atenuada e imunogênica, e, composição imunogênica.
DE69837764T2 (de) 1997-07-11 2008-01-31 Yale University, New Haven Rhabdovirus mit gentechnisch veränderter hülle
KR20010030630A (ko) 1997-09-19 2001-04-16 윌리암 에이취 캘넌, 에곤 이 버그 약독화 호흡 신시티아 바이러스
US6146642A (en) 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines
EP1035209A1 (en) 1999-03-06 2000-09-13 ARTEMIS Pharmaceuticals GmbH Stable recombinant influenza viruses free of helper viruses
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
DE122008000035I1 (de) 1999-04-06 2009-05-20 Wisconsin Alumni Res Found Rekombinante influenzaviren zur vakzinherstellung und gentherapie
WO2001064860A2 (en) 2000-03-02 2001-09-07 Polymun Scientific Immunbiologische Forschung Gmbh Recombinant influenza a viruses
ES2319864T3 (es) 2000-04-28 2009-05-14 St. Jude Children's Research Hospital Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
JP5063852B2 (ja) 2000-09-25 2012-10-31 ポリマン サイエンティフィック イミューンバイオロジッシュ フォーシュング ゲゼルシャフト ミット ベシュレンクテル ファフツング 生ワクチン及び製造方法
USPP15035P3 (en) * 2001-06-27 2004-07-27 Marko Zaninovich, Inc. Grapevine ‘12-76-71’
KR100600988B1 (ko) * 2002-03-13 2006-07-13 주식회사 엘지생명과학 Dna 면역화에서 인플루엔자 np 유전자 dna를 함께투여하여 면역반응을 증가시키는 방법
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
DK1499348T3 (en) * 2002-04-26 2015-01-05 Medimmune Llc PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
US7566458B2 (en) 2003-06-16 2009-07-28 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US7037707B2 (en) 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines
JP4980895B2 (ja) 2004-05-25 2012-07-18 メディミューン,エルエルシー インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
EP2388340B1 (en) 2004-11-01 2013-04-03 Eiken Kagaku Kabushiki Kaisha Method of detecting H7 avian influenza virus
EP2471552B1 (en) 2005-03-08 2015-05-06 MedImmune, LLC Reassortant influenza viruses
RU2315101C2 (ru) * 2006-01-10 2008-01-20 ГУ "Научно-исследовательский институт экспериментальной медицины "Российской Академии медицинских наук (ГУ НИИЭМ РАМН) Вакцинный штамм вируса гриппа а/17/калифорния/ 04/6 (н3n2) и донор аттенуации а/ленинград/134/17/к7/57 (н2n2) для его получения
CN104140958A (zh) 2006-08-09 2014-11-12 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
WO2009014919A2 (en) * 2007-07-13 2009-01-29 Iowa State University Research Foundation, Inc. H2n3 influenza a viruses and methods of use
SG173642A1 (en) 2009-02-12 2011-09-29 Medimmune Llc Influenza hemagglutinin and neuraminidase variants

Similar Documents

Publication Publication Date Title
Chen et al. Advances in development and application of influenza vaccines
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
NZ596823A (en) Swine influenza hemagglutinin variants
HRP20171213T1 (hr) Glikoproteinske čestice nalik virusu (vlp) bjesnoće
JP2012531205A5 (https=)
CN105518129B (zh) 减毒流感疫苗和其用途
Jang et al. Principles underlying rational design of live attenuated influenza vaccines
CN104232594B (zh) 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用
JP2012517239A5 (https=)
JP2009535306A5 (https=)
JP2017502662A5 (https=)
RU2014140731A (ru) Варианты гемагглютинина и нейраминидазы гриппа
CN102220293B (zh) 犬流感重组病毒及其制备方法和应用
RU2018130683A (ru) Аттенуированный вирус инфекционного бронхита
JP2014502143A5 (https=)
Balamurugan et al. Past and present vaccine development strategies for the control of foot-and-mouth disease
CN111481663B (zh) 一种流感病毒活疫苗及其制备方法
Lee et al. Genetic evolution of H5 highly pathogenic avian influenza virus in domestic poultry in Vietnam between 2011 and 2013
Yi et al. Molecular characterization of a virulent genotype VIId strain of Newcastle disease virus from farmed chickens in Shanghai
JP7849046B2 (ja) インフルエンザウイルスバックボーン
CN103316357A (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
CN103865923B (zh) 流感病毒为载体的HAdV嵌合疫苗的制备及其应用
JP5884100B2 (ja) 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するDIs株由来組換えワクシニアウイルス
RU2017105223A (ru) Аттенуированный штамм вируса репродуктивно-респираторного синдрома свиней (ррсс) и его возможное применение в средствах для иммунизации
CN105861450B (zh) 一种中国虹鳟传染性造血器官坏死病核酸疫苗及其应用